Testosterone cypionate is a long-acting esterified form of the endogenous androgen testosterone. The compounded product is formulated in grapeseed oil for intramuscular administration; it is compounded in concentrations ranging from 20 mg/mL to 200 mg/mL across 1 mL, 2·5 mL, 5 mL, 10 mL and 30 mL multi-dose vials, allowing prescribers to match dose and vial size precisely to patient requirements.
As an individualized preparation produced under sections 503A or 503B of the U.S. Federal Food, Drug, and Cosmetic Act, each batch may be tailored for a single named patient or manufactured in larger lots for office use, yet in both scenarios the formulation must meet pharmaceutical quality standards for sterility, potency and particulate control.
Clinically, both commercial and compounded testosterone cypionate is prescribed for adult males with confirmed hypogonadism who exhibit symptoms such as reduced muscle mass, diminished libido, erectile dysfunction, fatigue or mood disturbance and in whom morning serum testosterone levels on two separate days fall below the young-adult reference range.
Because the product is an anabolic-androgenic steroid classified as a Schedule III controlled substance it may only be dispensed pursuant to a valid prescription, must be stored securely and is subject to state and federal monitoring programs aimed at preventing diversion and misuse.
The nature of the compounded formulation of testosterone cypionate means inactive components, usually limited to grapeseed oil and possibly a bacteriostatic agent, can be adjusted to address allergies or other patient-specific considerations, thereby offering flexibility beyond what is available with a single commercial brand while still requiring physician oversight and periodic laboratory monitoring to ensure both efficacy and safety.




Reviews
There are no reviews yet.